Notice of Change to Receipt Dates for RFA-NS-24-013: Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
National Institutes of Health
Posted on:
Type
Research/project funding
Notice NOT-NS-24-044 from the NIH Guide for Grants and Contracts